Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
Murray CJL., Vos T., Lozano R., Naghavi M., Flaxman AD., Michaud C., Ezzati M., Shibuya K., Salomon JA., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn SY., Ali MK., Alvarado M., Anderson HR., Anderson LM., Andrews KG., Atkinson C., Baddour LM., Bahalim AN., Barker-Collo S., Barrero LH., Bartels DH., Basáñez M-G., Baxter A., Bell ML., Benjamin EJ., Bennett D., Bernabé E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black JA., Blencowe H., Blore JD., Blyth F., Bolliger I., Bonaventure A., Boufous S., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha TS., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G., Budke CM., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter CE., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H., Cheng AT-A., Chou D., Chugh SS., Coffeng LE., Colan SD., Colquhoun S., Colson KE., Condon J., Connor MD., Cooper LT., Corriere M., Cortinovis M., de Vaccaro KC., Couser W., Cowie BC., Criqui MH., Cross M., Dabhadkar KC., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais DC., Dharmaratne SD., Dherani M., Diaz-Torne C., Dolk H., Dorsey ER., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali SE., Erskine H., Erwin PJ., Espindola P., Ewoigbokhan SE., Farzadfar F., Feigin V., Felson DT., Ferrari A., Ferri CP., Fèvre EM., Finucane MM., Flaxman S., Flood L., Foreman K., Forouzanfar MH., Fowkes FGR., Fransen M., Freeman MK., Gabbe BJ., Gabriel SE., Gakidou E., Ganatra HA., Garcia B., Gaspari F., Gillum RF., Gmel G., Gonzalez-Medina D., Gosselin R., Grainger R., Grant B., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa YA., Hall W., Haring D., Haro JM., Harrison JE., Havmoeller R., Hay RJ., Higashi H., Hill C., Hoen B., Hoffman H., Hotez PJ., Hoy D., Huang JJ., Ibeanusi SE., Jacobsen KH., James SL., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas JB., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J-P., King CH., Knowlton LM., Kobusingye O., Koranteng A., Krishnamurthi R., Laden F., Lalloo R., Laslett LL., Lathlean T., Leasher JL., Lee YY., Leigh J., Levinson D., Lim SS., Limb E., Lin JK., Lipnick M., Lipshultz SE., Liu W., Loane M., Ohno SL., Lyons R., Mabweijano J., MacIntyre MF., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis DJ., Marks GB., Marks R., Matsumori A., Matzopoulos R., Mayosi BM., McAnulty JH., McDermott MM., McGill N., McGrath J., Medina-Mora ME., Meltzer M., Mensah GA., Merriman TR., Meyer A-C., Miglioli V., Miller M., Miller TR., Mitchell PB., Mock C., Mocumbi AO., Moffitt TE., Mokdad AA., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch ME., Mwaniki MK., Naidoo K., Nair MN., Naldi L., Narayan KMV., Nelson PK., Nelson RG., Nevitt MC., Newton CR., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer SB., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian JD., Rivero AP., Patten SB., Pearce N., Padilla RP., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips MR., Pierce K., Pion S., Polanczyk GV., Polinder S., Pope CA., Popova S., Porrini E., Pourmalek F., Prince M., Pullan RL., Ramaiah KD., Ranganathan D., Razavi H., Regan M., Rehm JT., Rein DB., Remuzzi G., Richardson K., Rivara FP., Roberts T., Robinson C., De Leòn FR., Ronfani L., Room R., Rosenfeld LC., Rushton L., Sacco RL., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel DC., Scott JG., Segui-Gomez M., Shahraz S., Shepard DS., Shin H., Shivakoti R., Singh D., Singh GM., Singh JA., Singleton J., Sleet DA., Sliwa K., Smith E., Smith JL., Stapelberg NJC., Steer A., Steiner T., Stolk WA., Stovner LJ., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor HR., Taylor JA., Taylor WJ., Thomas B., Thomson WM., Thurston GD., Tleyjeh IM., Tonelli M., Towbin JA., Truelsen T., Tsilimbaris MK., Ubeda C., Undurraga EA., van der Werf MJ., van Os J., Vavilala MS., Venketasubramanian N., Wang M., Wang W., Watt K., Weatherall DJ., Weinstock MA., Weintraub R., Weisskopf MG., Weissman MM., White RA., Whiteford H., Wiebe N., Wiersma ST., Wilkinson JD., Williams HC., Williams SRM., Witt E., Wolfe F., Woolf AD., Wulf S., Yeh P-H., Zaidi AKM., Zheng Z-J., Zonies D., Lopez AD., AlMazroa MA., Memish ZA.
BACKGROUND: Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. METHODS: We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. FINDINGS: Global DALYs remained stable from 1990 (2·503 billion) to 2010 (2·490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. INTERPRETATION: Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results. FUNDING: Bill & Melinda Gates Foundation.